toxoid

(redirected from diphtheria toxoid)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to diphtheria toxoid: diphtheria antitoxin, tetanus toxoid

tox·oid

 (tŏk′soid′)
n.
A substance that has been treated to destroy its toxic properties but retains the capacity to stimulate production of antitoxins, used in immunization.

toxoid

(ˈtɒksɔɪd)
n
(Medicine) a toxin that has been treated to reduce its toxicity and is used in immunization to stimulate production of antitoxins

tox•oid

(ˈtɒk sɔɪd)
n.
a bacterial toxin rendered harmless by chemicals and used for inducing immunity.
[1890–95]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.toxoid - a bacterial toxin that has been weakened until it is no longer toxic but is strong enough to induce the formation of antibodies and immunity to the specific disease caused by the toxin; "diphtheria toxoid"
bacterial toxin - any endotoxin or exotoxin formed in or elaborated by bacterial cells
antigen - any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)
Translations

tox·oid

n. toxoide, toxina desprovista de toxicidad que al introducirse en el organismo causa la formación de anticuerpos;
a. toxoide, de naturaleza tóxica o venenosa;
diphtheria ______ diftérico;
tetanus ______ tetánico.

toxoid

n toxoide m; diphtheria — toxoide diftérico; tetanus — toxoide tetánico
References in periodicals archive ?
After the diphtheria toxoid vaccine was introduced, a decline in diphtheria cases was seen where the vaccine was used.
Food and Drug Administration (FDA) has approved BOOSTRIX [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 65 years of age and older for active booster immunization against tetanus, diphtheria and pertussis (whooping cough).
In 2005, sanofi pasteur continued its tradition of innovation by introducing Menactra(R), Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine to protect against meningococcal disease in adolescents and adults, 11-55 years of age, and ADACEL(R), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed as a booster dose for protection against tetanus, diphtheria and pertussis in both adolescents and adults 11-64 years of age.
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
coniug - Lot 3 ATC: J07AM51 - tetanus toxoid in combination with diphtheria toxoid.
In 2005, sanofi pasteur continued its tradition of innovation by introducing MENACTRA(R) (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate) vaccine to protect against meningococcal disease in adolescents and adults, 11-55 years of age, and ADACEL(TM) (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed) as a booster dose for protection against tetanus, diphtheria and pertussis in adolescents and adults 11-64 years of age.
The tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed (Tdap) was licensed in June for use as a single-dose booster immunization in persons aged 11-64 and was previously recommended by ACIP for use in adolescents.
Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed) is indicated as a booster for adolescents and adults aged 11-64 years, while Boostrix is indicated for adolescents aged 10-18 years.
Supply of vaccines, the vaccine against hepatitis A vaccine for adults and diphtheria toxoid.
Like the tetanus-diphtheria (Td) vaccine that it replaces, the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed (Tdap) is routinely recommended at intervals of 10 years for all adults.
The technology will first be introduced on two Sanofi Pasteur vaccines - pediatric Diphtheria and Tetanus Toxoid Adsorbed (DT) vaccine, and Menactra[R] Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate vaccine.

Full browser ?